Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Narrative therapy for older adults with depression

Official title: Efficacy of Narrative Therapy for Older People With Depression

Run by City University of Hong Kong · NCT07371988 · Data updated 2026-11-12

This project will test whether an eight-session narrative therapy group can reduce depressive symptoms in people aged 60 and over who use local elderly centres.

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment110 (estimated)
SponsorCity University of Hong Kong
Academic / other
Locations1 site (Kowloon Tong, Hong Kong)
StatusRecruiting
StartedNovember 10, 2025
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedApril 24, 2026
Trial IDNCT07371988 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults aged 60 or older who use local elderly centre services, have mild-to-moderate depressive symptoms (BDI-II 10–30), can give informed consent, and can attend in-person group sessions.

Probably not a fit

People with severe depression (BDI ≥31), dementia, psychosis, or active suicidal thoughts are excluded and unlikely to benefit from this group intervention, and individuals unable to attend in-person sessions may also not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-methods research uses a multicentre randomized waitlist-controlled design to compare an eight-session narrative therapy group with treatment-as-usual in older adults. Eligible participants (aged 60+ with BDI-II scores 10–30) will be recruited from local elderly centres in Hong Kong and randomised 1:1 using block randomisation. Trained social workers or counsellors will deliver the group intervention, and standardized measures of depressive symptoms will be collected before and after treatment; a qualitative component will explore participants' experiences and perceived benefits or limitations. People with severe depression (BDI ≥31), dementia, psychosis, or active suicidal thoughts are excluded from participation.

Why it matters

Potential benefit: If successful, the program could offer a low-cost, community-delivered option to reduce depressive symptoms and self-stigma among older adults.

How similar studies have gone: Previous small trials and pilot studies of group narrative and other psychotherapeutic approaches have shown promise for reducing depressive symptoms and self-stigma, but randomized controlled evidence specifically in older adults is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 60 years or above;
2. exhibiting depressive symptoms as assessed using a standardised assessment tool, namely the Chinese Beck Depression Inventory-II (BDI; Byrne et al., 2004), with a BDI score between 10 and 30;
3. being a service user of an elderly centre; and
4. providing informed consent to participate in this research.

Exclusion Criteria:

1. Individuals with severe depression (i.e. a BDI score ≥ 31), dementia, psychosis, or self-reported suicidal thoughts are excluded from this study; and
2. Individuals currently receiving a therapeutic intervention are not excluded from this study.

Where it's running

  • City University of Hong Kong
    Kowloon Tong, Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Kim-wan Daniel Young, PhD — City University of Hong Kong
  • Study coordinator: Kim-wan Daniel Young, PhD
  • Email: dkwyoung@cityu.edu.hk
  • Phone: +852 3442 8954

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.